APA (7th ed.) Citation

S, A., DC, M., AI, B., R, T., I, N., AH, A., . . . M, P. (2026). Histopathological Changes Following Bromelain-Based Enzymatic Debridement (NexoBrid®): A Comprehensive Systematic Review of Preclinical and Clinical Evidence. Medical sciences (Basel, Switzerland), 14(1), . https://doi.org/10.3390/medsci14010157

Chicago Style (17th ed.) Citation

S, Avadanei-Luca, Moraru DC, Bulgaru-Iliescu AI, Tatar R, Nacea I, Amarandei AH, Constantinescu MC, and Pertea M. "Histopathological Changes Following Bromelain-Based Enzymatic Debridement (NexoBrid®): A Comprehensive Systematic Review of Preclinical and Clinical Evidence." Medical Sciences (Basel, Switzerland) 14, no. 1 (2026). https://doi.org/10.3390/medsci14010157.

MLA (9th ed.) Citation

S, Avadanei-Luca, et al. "Histopathological Changes Following Bromelain-Based Enzymatic Debridement (NexoBrid®): A Comprehensive Systematic Review of Preclinical and Clinical Evidence." Medical Sciences (Basel, Switzerland), vol. 14, no. 1, 2026, https://doi.org/10.3390/medsci14010157.